Alexander Snyder. (2021). For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies. Pittsburgh Journal of Technology Law &Amp; Policy, 21(2). https://doi.org/10.5195/tlp.2021.251